Large cell neuroendocrine carcinoma of the lung: A retrospective analysis of 144 surgical cases

Lung Cancer

Volumn 53, Issue 1, 2006, Pages 111-115

  Veronesi, Giulia ^a   Morandi, Uliano ^b   Alloisio, Marco ^c   Terzi, Alberto ^d   Cardillo, Giuseppe ^e   Filosso, Pierluigi ^f   Rea, Federico ^g   Facciolo, Francesco ^h   Pelosi, Giuseppe ^a,i   Gandini, Sara ^a   Calabrò, Francesco ^d   Casali, Christian ^b   Marulli, Giuseppe ^g   Spaggiari, Lorenzo ^a,i  

^a EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

^b UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^c Thoracic Surgery   (Italy)

^d Verona Hospital   (Italy)

^e SAN CAMILLO FORLANINI HOSPITAL   (Italy)

^f UNIVERSITY OF TURIN   (Italy)

^g UNIVERSITY OF PADOVA   (Italy)

^h REGINA ELENA NATIONAL CANCER INSTITUTE   (Italy)

ⁱ UNIVERSITY OF MILAN   (Italy)

Author keywords

Lung cancer; Neuroendocrine tumors; Prognosis; Surgery

Indexed keywords

GEMCITABINE; NAVELBINE; PACLITAXEL; PLATINUM;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; FEMALE; FOLLOW UP; HUMAN; KAPLAN MEIER METHOD; LARGE CELL CARCINOMA; LOBECTOMY; LOG RANK TEST; LUNG CARCINOMA; LUNG RESECTION; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MORBIDITY; MULTIMODALITY CANCER THERAPY; NEUROENDOCRINE TUMOR; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SURGICAL TECHNIQUE; SURVIVAL TIME; TIME SERIES ANALYSIS;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, LARGE CELL; CARCINOMA, NEUROENDOCRINE; CHEMOTHERAPY, ADJUVANT; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 33744795445     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lungcan.2006.03.007     Document Type: Article

References (22)

1. Hammond M.E., and Sause W.T. Large cell neuroendocrine tumors of the lung. Clinical significance and histopathologic definition. Cancer 56 7 (1985) 1624-1629
2. Warren W.H., Gould V.E., Faber L.P., kittle C.F., and Memoli V.A. Neuroendocrine neoplasms of the bronchopulmonary tract. Classification of the spectrum of carcinoid to small cell carcinoma and intervening variants. J Thoac Cardiovasc Surg 89 (1985) 819-825
3. Travis W.D., Linnoila R.I., Tsokos M.G., Hitchcock C.L., Cutler Jr. G.B., Nieman L., et al. Neuroendocrine tumors of the lung with proposed criteria for large cell neuroendocrine carcinoma. An ultrastructural, immunohistochemical, and flow cytometric study of 35 cases. Am Jurn Surg Pathol 15 (1991) 529-553
4. Warren W.H., Faber L.P., and Gould V.E. Neuroendocrine neoplasms of the lung. A clinicopathologic update. J Thorac Cardiovasc Surg 98 (1989) 798-810
5. Jiang S.X., Kameya T., Shoji M., Dobashi Y., Shinada J., and Yoshimura H. Large cell neuroendocrine carcinoma of the lung: a histologic and immunohistochemical study of 22 cases. Am J Surg Pathol 22 5 (1998) 526-537
6. Dresler C.M., Ritter J.H., Patterson G.A., Ross E., Bailey M.S., and Wick M.R. Clinical-pathologic analysis of 40 patients with large cell neuroendocrine carcinoma of the lung. Ann Thorac Surg 63 1 (1997) 180-185
7. Travis W.D., Rush W., Flieder D.B., Falk R., Fleming M.V., Gal A.A., et al. Survival analysis of 200 pulmonary neuroendocrine tumors with clarification of criteria for atypical carcinoid and its separation from typical carcinoid. Am J Surg Pathol 22 8 (1998) 934-944
8. Garcia-Yuste M., Matilla J.M., Alvarez-Gago T., Duque J.L., Heras F., Cerezal L.J., et al. Prognostic factors in neuroendocrine lung tumors: a Spanish Multicenter Study. Spanish Multicenter Study of Neuroendocrine Tumors of the Lung of the Spanish Society of Pneumonology and Thoracic Surgery (EMETNE-SEPAR). Ann Thorac Surg 70 1 (2000) 258-263
9. Iyoda A., Hiroshima K., Toyozaki T., Haga Y., Fujisama T., and Ohwada H. Clinical characterization of pulmonary large cell neuroendocrine and large cell carcinoma with neuroendocrine morphology. Cancer 91 (2001) 1992-2000
10. Takei H., Asamura H., Maeshima A., Suzuki K., Kondo H., Niki T., et al. Large cell neuroendocrine carcinoma of the lung: a clinicopathologic study of eighty-seven cases. J Thorac Cardiovasc Surg 124 2 (2002) 285-292
11. Zacharias J., Nicholson A.G., Ladas G.P., and Goldstraw P. Large cell neuroendocrine carcinoma and large cell carcinomas with neuroendocrine morphology of the lung: prognosis after complete resection and systematic nodal dissection. Ann Thorac Surg 75 2 (2003) 348-352
12. Paci M., Cavazza A., Annessi V., Putrino I., Ferrari G., De Franco S., et al. Large cell neuroendocrine carcinoma of the lung: a 10-year clinicopathologic retrospective study. Ann Thorac Surg 77 4 (2004) 1163-1167
13. Asamura H., Kameya T., Matsuno Y., Noguchi M., Tada H., Ishikawa Y., et al. Neuroendocrine neoplasms of the lung: a prognostic spectrum. J Clin Oncol 24 1 (2006) 70-76
14. World Health Organization. Histological typing of lung and pleural tumors. 3rd ed. (1999), Springer-Verlag, Berlin
15. Naruke T., Goya T., Tsuchiya R., and Suemasu K. Prognosis and survival in resected lung carcinoma based on the new international staging system. Thorac Cardiovasc Surg 96 (1988) 440-447
16. Mountain C.F. Revisions in the international system for staging lung cancer. Chest 111 (1997) 1710-1717
17. Shepherd F.A., Ginsberg R.J., Patterson G.A., Evans W.K., and Feld R. A prospective study of adjuvant surgical resection after chemotherapy for limited SCLC. A University of Toronto Lung Oncology Group study. Thorac Cardiovasc Surg 97 (1989) 177-186
18. Shields T.W., Higgins Jr. G.A., Matthews M.J., and Keehn R.J. Surgical resection in the management of small cell carcinoma of the lung. J Thorac Cardiovasc Surg 84 (1982) 481-488
19. Rossi G., Cavazza A., Marchioni A., Longo L., Migaldi M., Sartori G., et al. Role of chemotherapy and the receptor tyrosine kinases KIT, PDGFRalpha, PDGFRbeta, and met in large-cell neuroendocrine carcinoma of the lung. J Clin Oncol 23 34 (2005) 8774-8785
20. Iyoda A., Hiroshima K., Toyozaki T., Haga Y., Baba M., Fujisama T., et al. Adjuvant chemotherapy for large cell carcinoma with neuroendocrine features. Cancer 92 (2001) 1108-1112
21. Graziano S.L., Mazid R., Newman T., Tatum A., Oler A., and Mortimer J.A. The use of neuroendocrine immunoperoxidase marker to predict chemotherapy response in patients with non-small cell lung cancer. J Clin Oncol 7 (1989) 1398-1406
22. Winton T., Livingston R., Johnson D., Rigas J., Johnston M., Butts C., et al. Vinorelbine plus cisplatin vs. observation in resected non-small cell lung cancer. NEJM 352 (2005) 2589-2597